Residual Risk of Hyperkalemia Among Patients with Heart Failure Treated with Both SGLT2i and ARNI. // Journal of Cardiac Failure. – URL: https://www.sciencedirect.com/science/article/pii/S1071916426001879?dgcid=rss_sd_all
Residual Risk of Hyperkalemia Among Patients with Heart Failure Treated with Both SGLT2i and ARNI. Journal of Cardiac Failure. https://www.sciencedirect.com/science/article/pii/S1071916426001879?dgcid=rss_sd_all
“Residual Risk of Hyperkalemia Among Patients with Heart Failure Treated with Both SGLT2i and ARNI.” Journal of Cardiac Failure.
@article{article117033,
title = {Residual Risk of Hyperkalemia Among Patients with Heart Failure Treated with Both SGLT2i and ARNI},
journal = {Journal of Cardiac Failure},
url = {https://www.sciencedirect.com/science/article/pii/S1071916426001879?dgcid=rss_sd_all}
}